AAAAAA

   
Results: 1-10 |
Results: 10
ELECTROCHEMOTHERAPY WITH CISPLATIN - POTENTIATION OF LOCAL CISPLATIN ANTITUMOR EFFECTIVENESS BY APPLICATION OF ELECTRIC PULSES IN CANCER-PATIENTS
Authors: SERSA G STABUC B CEMAZAR M JANCAR B MIKLAVCIC D RUDOLF Z
Citation: G. Sersa et al., ELECTROCHEMOTHERAPY WITH CISPLATIN - POTENTIATION OF LOCAL CISPLATIN ANTITUMOR EFFECTIVENESS BY APPLICATION OF ELECTRIC PULSES IN CANCER-PATIENTS, European journal of cancer, 34(8), 1998, pp. 1213-1218
SERUM TNF-ALPHA AND SOLUBLE TNF RECEPTORS P55 IN MELANOMA PATIENTS
Authors: OCVIRK J STABUC B CURIN V ZUMEC P
Citation: J. Ocvirk et al., SERUM TNF-ALPHA AND SOLUBLE TNF RECEPTORS P55 IN MELANOMA PATIENTS, Annals of oncology, 9, 1998, pp. 561-561
TREATMENT OPTIONS IN WESTERN HEPATOCELLULAR-CARCINOMA - A PROSPECTIVE-STUDY OF 224 PATIENTS
Authors: MARKOVIC S GADZIJEV E STABUC B CROCE LS MASUTTI F SURLAN M BERDEN P BRENCIC E VISNARPEROVIC A SASSO F FERLANMAROLT V MUCELLI FP CESAR R SPONZA M TIRIBELLI C
Citation: S. Markovic et al., TREATMENT OPTIONS IN WESTERN HEPATOCELLULAR-CARCINOMA - A PROSPECTIVE-STUDY OF 224 PATIENTS, Journal of hepatology, 29(4), 1998, pp. 650-659
EFFECTIVE TREATMENT OF CUTANEOUS AND SUBCUTANEOUS MALIGNANT-TUMORS BYELECTROCHEMOTHERAPY
Authors: MIR LM GLASS LF SERSA G TEISSIE J DOMENGE C MIKLAVCIC D JAROSZESKI MJ ORLOWSKI S REINTGEN DS RUDOLF Z BELEHRADEK M GILBERT R ROLS MP BELEHRADEK J BACHAUD JM DECONTI R STABUC B CEMAZAR M CONINX P HELLER R
Citation: Lm. Mir et al., EFFECTIVE TREATMENT OF CUTANEOUS AND SUBCUTANEOUS MALIGNANT-TUMORS BYELECTROCHEMOTHERAPY, British Journal of Cancer, 77(12), 1998, pp. 2336-2342
CATHEPSIN-B, CATHEPSIN-H, AND CATHEPSIN-L AND THEIR INHIBITORS STEFIN-A AND CYSTATIN-C IN SERA OF MELANOMA PATIENTS
Authors: KOS J STABUC B SCHWEIGER A KRASOVEC M CIMERMAN N KOPITARJERALA N VRHOVEC I
Citation: J. Kos et al., CATHEPSIN-B, CATHEPSIN-H, AND CATHEPSIN-L AND THEIR INHIBITORS STEFIN-A AND CYSTATIN-C IN SERA OF MELANOMA PATIENTS, Clinical cancer research, 3(10), 1997, pp. 1815-1822
INCREASED SERUM LEVELS OF SOLUBLE RECEPTOR FOR TUMOR-NECROSIS-FACTOR P-55 IN MELANOMA PATIENTS
Authors: STABUC B OCVIRK J PLESNICAR A CURIN V ZUNEC P ROZMAN P
Citation: B. Stabuc et al., INCREASED SERUM LEVELS OF SOLUBLE RECEPTOR FOR TUMOR-NECROSIS-FACTOR P-55 IN MELANOMA PATIENTS, European journal of cancer, 33, 1997, pp. 1174-1174
EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS
Authors: CASTIGLIONEGERTSCH M GOLDHIRSCH A GUSTERSON B BETTELHEIM R REED R GUSSET H GEISER K HURNY C BERNHARD J HANGARTNER A MAIBACH R PEDOWSKI R GELBER R PRICE K PETERSON H ZELEN M ISLEY M HINKLE R KAY RG HOLDAWAY IM HARVEY VJ JAGUSCH MF NEAVE L MASON BM EVANS B BENJAMIN CS CARTER JF GILLMAN JC MACK D BENSONCOOPER D MONFARDINI S GALLIGIONI E CRIVELLARI D BUONADONNA A MASSARUT S ROSSI C CANDIANI E CARBONE A VOLPE R TROVO MG RONCADIN M SANTINI GF VILLALTA D CORAN F MORASSUT S MARINI G SIMONCINI E MARPICATI P ZANIBONI A SARTORI U BARNI A CERUTTI L ALGHISI A RAFFAGLIO E GARATTINI MP ALBERTINI A GRIGOLATO F MORASSI L BERGONZINI R LAURIOLA C GUDGEON A DENT DM TILTMAN A HACKING A DOWDLE E STEYNOR P TOOP J SCHNURCH HG MOSNY D BENDER HG BOJAR H VERONESI A FOLADORE S PAMICH G BIANCHI G TORRETTA A RUDENSTAM CM WALLGREN A PERSSON S MATTSSON J CAHLIN E HAFSTROM LO HOLMBERG S HULTBORN R COLLDAHLJADERSTROM G GUSTAVSSON B CARLSSON G IVARSSON L THOREN O RUUSVIK O NICKLASSON LG DAHLIN S KARLSSON G LINDBERG B SUNDBACK A BERGEGARDH S SALANDER H ANDERSSON C HESSMAN Y NELZEN O HEIDEMAN M RAMHULT T SVENSSON JH LIDBERG P BJORK S LINDTNER J ERZEN D CERAR O STABUC B GOLOUH R LAMOVEC J SEBEK S KRAMBERGER M VRHOVEC I CORTESFUNES H MARTINEZTELLO F MENDIOLA C CRUZVIGO F LARRODERA ML SIERRA A MIRANDA P ALONSO S COLLINS J SNYDER R GREGORY P BURAS WI GREEN M GALE T HENDERSON M HART S NEIL S KITCHEN P LOVELL R MCLENNAN R REED R RUSSELL I SCHWARZ M BASSER R ROBERTSON A GILL P CARTER ML MALYCHA P YEOH E WARD G LEONG ASY LOMMAXSMITH J HOOSFALL D DANGELO R BYRNE M VANHAZEL G DEWAR J BUCK M SHEINER HJ INGRAM D STERRETT G HAHNEL R FORBES JF STEWARD J DARBAR SW BISHOP JM SIMMS B ZIOGAS V TATTERSALL MHN COATES A NIESCHE F WEST R RENWICK S DONOVAN J DUVAL P SIMES RJ NG A GLENN D NORTH RA BEITH J OCONNOR RG RICE M STEVENS G FEY M BARTH A DREHER E ISENSCHMID M SCHNEIDER H BUSER K LUDIN J LUTHI JM ALTERMATT HJ LAISSUE JA MARKWALDER R BURGI H SENN HJ THURLIMANN B JUNGI WF MORANT R OEHLSCHLEGEL C HARDMEIER T LUSCHER K RIES G TOPFER M LORENZ U BENZ D SCHILTKNECHT O SPATI B SCHMID L CAVALLI F SESSA C BRONZ L MARTINELLI G MULLER W LUSCIETI P PASSEGA E PEDRINIS E REY P MARTINOLI S SPINELLI A GALFETTI MA LOMBARDI A PEDRAZZINI A LOSA G VARINI M GINIER M HERRMANN R HARDER JF LAFFER U ALMENDRAL AC EPPENBERGER U TORHORST J SIEGENTHALER P PIGUET D BARRELET V BAUMANN RP JOSS R SAUTER C METZGER U ENGELER V HALLER U KOCHLI O LEYVRAZ S PEREY L ANANI P GOMEZ F MIRIMANOFF RO CHAPUIS G DEGRANDI P REYMOND P ALBERTO P SCHAFER P KRAUER F FORNI M AAPRO M EGELI R MEGEVAND R JACOTDESCOMBES E SCHINDLER A NOSEDA G WEBER W LEHMANN W
Citation: M. Castiglionegertsch et al., EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1385-1394
ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR THE DETECTION OF TOTAL CATHEPSIN-H IN HUMAN TISSUE CYTOSOLS AND SERA
Authors: SCHWEIGER A STABUC B POPOVIC T TURK V KOS J
Citation: A. Schweiger et al., ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR THE DETECTION OF TOTAL CATHEPSIN-H IN HUMAN TISSUE CYTOSOLS AND SERA, Journal of immunological methods, 201(2), 1997, pp. 165-172
UKRAIN WITH CHEMOTHERAPY IN MALIGNANT-MELANOMA (CASE-REPORT)
Authors: STABUC B BENEDICIC D
Citation: B. Stabuc et D. Benedicic, UKRAIN WITH CHEMOTHERAPY IN MALIGNANT-MELANOMA (CASE-REPORT), Drugs under experimental and clinical research, 22(3-5), 1996, pp. 231-233
A PHASE-II TRIAL OF CARDIOPROTECTION WITH CARDIOXANE (ICRF-187) IN PATIENTS WITH ADVANCED BREAST-CANCER RECEIVING 5-FLUOROURACIL, DOXORUBICIN AND CYCLOPHOSPHAMIDE
Authors: KOLARIC K BRADAMANTE V CERVEK J CIESLINSKA A CISARZFILIPCAK E DENISOV LE DONAT D DROSIK K GERSHANOVIC M HUDZIEC P JELIC S JURGA L KALASIEWICZ M KOWGIRD L KOZACKA M LICHINITZER M MACHALSKI M MECHL Z ODINTSOV S PAWLICKI M RUBACH D ROTH A STABUC B TOMCZAK J UTRACKA B ZBORZIL J ROGAN J
Citation: K. Kolaric et al., A PHASE-II TRIAL OF CARDIOPROTECTION WITH CARDIOXANE (ICRF-187) IN PATIENTS WITH ADVANCED BREAST-CANCER RECEIVING 5-FLUOROURACIL, DOXORUBICIN AND CYCLOPHOSPHAMIDE, Oncology, 52(3), 1995, pp. 251-255
Risultati: 1-10 |